• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

瑞典遗传性血管性水肿成年患者的健康相关生活质量与疾病活动的关系

Health-related quality of life in relation to disease activity in adults with hereditary angioedema in Sweden.

作者信息

Nordenfelt Patrik, Nilsson Mats, Lindfors Anders, Wahlgren Carl-Fredrik, Björkander Janne

出版信息

Allergy Asthma Proc. 2017 Nov 30;38(6):447-455. doi: 10.2500/aap.2017.38.4087. Epub 2017 Aug 30.

DOI:10.2500/aap.2017.38.4087
PMID:28855002
Abstract

BACKGROUND

Health-related quality of life (HR-QoL) is impaired in patients with hereditary angioedema (HAE) but has not yet been satisfactorily described.

OBJECTIVE

To study HR-QoL in patients with HAE by combining different HR-QoL instruments with disease activity assessment.

METHODS

All adults in the Swedish HAE registry were invited to take part in this questionnaire study, which used the generic HR-QoL instruments, EuroQol 5 Dimensions 5 Level (EQ-5D-5L) and the RAND Corporation Short Form 36 (RAND-36), the disease-specific Angioedema Quality of Life instrument (AE-QoL), the recently introduced Angioedema Activity Score (AAS) form, and questionnaires on sick leave and prophylactic medication.

RESULTS

Sixty-four of 133 adults (26 men, 38 women) between 18 and 91 years old responded. The most affected HR-QoL dimensions in the EQ-5D-5L were pain/discomfort and anxiety/depression; in the RAND-36, energy/fatigue, general health, pain; and, in the AE-QoL, fears/shame and fatigue/mood. Women had lower HR-QoL in the RAND-36 for general health and energy/fatigue (p < 0.05). Patients who reported any AAS of >0 had significantly impaired HR-QoL. There were significant associations (p < 0.05) between the AAS and EQ-5D-5L, between the AAS and all dimensions of the RAND-36 except physical function, and between the AAS and AE-QoL in all dimensions. Nine of 36 patients who reported sick leave during the previous 4 weeks had significantly impaired HR-QoL in all the instruments (p < 0.05). There was no significant difference in HR-QoL in the patients with and the patients without prophylactic medication, except for the nutrition dimension of the AE-QoL (p < 0.05).

CONCLUSION

Comprehensive information is obtained by combining different HR-QoL instruments. Pain, anxiety/depression, and fatigue/mood are important aspects of HAE but the AE-QoL disregards pain. HR-QoL was not significantly affected by prophylaxis. Increased disease activity was associated with impaired HR-QoL, which justifies more active disease management.

摘要

背景

遗传性血管性水肿(HAE)患者的健康相关生活质量(HR-QoL)受损,但尚未得到令人满意的描述。

目的

通过将不同的HR-QoL工具与疾病活动评估相结合,研究HAE患者的HR-QoL。

方法

邀请瑞典HAE登记处的所有成年人参与这项问卷调查研究,该研究使用了通用的HR-QoL工具,即欧洲五维健康量表5级(EQ-5D-5L)和兰德公司36项简短健康调查(RAND-36)、疾病特异性血管性水肿生活质量工具(AE-QoL)、最近推出的血管性水肿活动评分(AAS)表,以及关于病假和预防性药物治疗的问卷。

结果

133名年龄在18至91岁之间的成年人(26名男性,38名女性)中有64人做出了回应。EQ-5D-5L中受影响最大的HR-QoL维度是疼痛/不适和焦虑/抑郁;在RAND-36中是精力/疲劳、总体健康、疼痛;在AE-QoL中是恐惧/羞耻和疲劳/情绪。女性在RAND-36中的总体健康和精力/疲劳方面的HR-QoL较低(p<0.05)。报告任何AAS>0的患者的HR-QoL显著受损。AAS与EQ-5D-5L之间、AAS与RAND-36除身体功能外的所有维度之间以及AAS与AE-QoL的所有维度之间均存在显著相关性(p<0.05)。在过去4周内报告病假的36名患者中有9名在所有工具中的HR-QoL均显著受损(p<0.05)。使用和未使用预防性药物治疗的患者在HR-QoL方面没有显著差异,但AE-QoL的营养维度除外(p<0.05)。

结论

通过结合不同的HR-QoL工具可获得全面信息。疼痛、焦虑/抑郁和疲劳/情绪是HAE的重要方面,但AE-QoL忽略了疼痛。预防性治疗对HR-QoL没有显著影响。疾病活动增加与HR-QoL受损相关,这证明需要更积极地管理疾病。

相似文献

1
Health-related quality of life in relation to disease activity in adults with hereditary angioedema in Sweden.瑞典遗传性血管性水肿成年患者的健康相关生活质量与疾病活动的关系
Allergy Asthma Proc. 2017 Nov 30;38(6):447-455. doi: 10.2500/aap.2017.38.4087. Epub 2017 Aug 30.
2
Quantifying the burden of disease and perceived health state in patients with hereditary angioedema in Sweden.量化瑞典遗传性血管性水肿患者的疾病负担和感知健康状况。
Allergy Asthma Proc. 2014 Mar-Apr;35(2):185-90. doi: 10.2500/aap.2014.35.3738. Epub 2014 Jan 9.
3
Content validation and psychometric evaluation of the Angioedema Quality of Life Questionnaire for hereditary angioedema.遗传性血管性水肿生活质量问卷的内容验证和心理计量学评估
J Patient Rep Outcomes. 2023 Apr 3;7(1):33. doi: 10.1186/s41687-023-00576-w.
4
Impact of lanadelumab on health-related quality of life in patients with hereditary angioedema in the HELP study.HELP 研究中拉那芦单抗对遗传性血管性水肿患者健康相关生活质量的影响。
Allergy. 2021 Apr;76(4):1188-1198. doi: 10.1111/all.14680. Epub 2020 Dec 24.
5
Prophylactic Treatment in Hereditary Angioedema Is Associated with Reduced Anxiety in Patients in Leipzig, Germany.德国莱比锡遗传性血管性水肿患者预防性治疗与焦虑降低相关。
Int Arch Allergy Immunol. 2021;182(9):819-826. doi: 10.1159/000514973. Epub 2021 Apr 22.
6
Psychometric Field Study of Hereditary Angioedema Quality of Life Questionnaire for Adults: HAE-QoL.遗传性血管性水肿成人生活质量问卷的心理测量学现场研究:HAE-QoL。
J Allergy Clin Immunol Pract. 2016 May-Jun;4(3):464-473.e4. doi: 10.1016/j.jaip.2015.12.010. Epub 2016 Mar 8.
7
Effect of COVID-19 on hereditary angioedema activity and quality of life.COVID-19 对遗传性血管性水肿活动和生活质量的影响。
Allergy Asthma Proc. 2021 Sep 1;42(5):403-408. doi: 10.2500/aap.2021.42.210066.
8
A validation study of the Japanese version of the Angioedema Activity Score (AAS) and the Angioedema Quality of Life Questionnaire (AE-QoL).血管性水肿活动评分(AAS)和血管性水肿生活质量问卷(AE-QoL)的日本版验证研究。
Allergol Int. 2021 Oct;70(4):471-479. doi: 10.1016/j.alit.2021.04.006. Epub 2021 May 20.
9
How Angioedema Quality of Life Questionnaire Can Help Physicians in Treating C1-Inhibitor Deficiency Patients?血管性水肿生活质量问卷如何帮助医生治疗 C1 抑制剂缺乏症患者?
Clin Rev Allergy Immunol. 2021 Aug;61(1):50-59. doi: 10.1007/s12016-021-08850-9. Epub 2021 Mar 3.
10
The Disease Burden and Societal Costs of Hereditary Angioedema.遗传性血管性水肿的疾病负担和社会成本。
J Allergy Clin Immunol Pract. 2023 Aug;11(8):2468-2475.e2. doi: 10.1016/j.jaip.2023.03.032. Epub 2023 Mar 27.

引用本文的文献

1
One-year real-life outcomes of lanadelumab therapy in Romanian patients with hereditary angioedema due to C1-inhibitor deficiency.罗马尼亚C1抑制剂缺乏所致遗传性血管性水肿患者接受lanadelumab治疗的1年真实生活结局
Front Allergy. 2025 Aug 21;6:1636425. doi: 10.3389/falgy.2025.1636425. eCollection 2025.
2
Impact of hereditary angioedema attacks on health-related quality of life and work productivity.遗传性血管性水肿发作对健康相关生活质量和工作生产力的影响。
World Allergy Organ J. 2025 Jul 28;18(8):101083. doi: 10.1016/j.waojou.2025.101083. eCollection 2025 Aug.
3
Quality of life in patients with hereditary angioedema correlates with angioedema control: Our experience at Chandigarh, India.
遗传性血管性水肿患者的生活质量与血管性水肿控制情况相关:我们在印度昌迪加尔的经验。
Asia Pac Allergy. 2025 Mar;15(1):1-6. doi: 10.5415/apallergy.0000000000000172. Epub 2025 Jan 13.
4
Dietary and physical trigger factors in hereditary angioedema: Self-conducted investigation and literature overview.遗传性血管性水肿的饮食和身体触发因素:自我调查与文献综述
Allergol Select. 2024 Nov 14;8:358-364. doi: 10.5414/ALX02523E. eCollection 2024.
5
Epidemiology, economic, and humanistic burden of hereditary angioedema: a systematic review.遗传性血管性水肿的流行病学、经济学和人文负担:系统评价。
Orphanet J Rare Dis. 2024 Jul 8;19(1):256. doi: 10.1186/s13023-024-03265-z.
6
The Disease Burden of Hereditary Angioedema: Insights from a Survey in French-Canadians from Quebec.遗传性血管性水肿疾病负担:魁北克省法裔加拿大人群调查的见解。
J Immunol Res. 2024 Mar 7;2024:3028617. doi: 10.1155/2024/3028617. eCollection 2024.
7
The estimation of health state utility values in rare diseases: do the approaches in submissions for NICE technology appraisals reflect the existing literature? A scoping review.罕见病健康状态效用值评估:英国国家卫生与临床优化研究所技术评估申请中的方法是否反映了现有文献? 范围综述。
Eur J Health Econ. 2023 Sep;24(7):1151-1216. doi: 10.1007/s10198-022-01541-y. Epub 2022 Nov 5.
8
The symptom experience of hereditary angioedema (HAE) patients beyond HAE attacks: literature review and clinician interviews.遗传性血管性水肿(HAE)患者除了 HAE 发作之外的症状体验:文献回顾和临床医生访谈。
Orphanet J Rare Dis. 2022 Jun 16;17(1):232. doi: 10.1186/s13023-022-02360-3.
9
The international WAO/EAACI guideline for the management of hereditary angioedema - The 2021 revision and update.国际血管性水肿学会(WAO)/欧洲变态反应和临床免疫学会(EAACI)遗传性血管性水肿管理指南——2021年修订与更新
World Allergy Organ J. 2022 Apr 7;15(3):100627. doi: 10.1016/j.waojou.2022.100627. eCollection 2022 Mar.
10
Psychometric study of the SF-36v2 in hereditary angioedema due to C1 inhibitor deficiency (C1-INH-HAE).SF-36v2 在 C1 抑制剂缺乏症(C1-INH-HAE)所致遗传性血管性水肿中的心理测量学研究。
Orphanet J Rare Dis. 2022 Mar 2;17(1):88. doi: 10.1186/s13023-022-02202-2.